Correlation Between VTv Therapeutics and Nabriva Therapeutics
Can any of the company-specific risk be diversified away by investing in both VTv Therapeutics and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VTv Therapeutics and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between vTv Therapeutics and Nabriva Therapeutics AG, you can compare the effects of market volatilities on VTv Therapeutics and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VTv Therapeutics with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VTv Therapeutics and Nabriva Therapeutics.
Diversification Opportunities for VTv Therapeutics and Nabriva Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between VTv and Nabriva is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding vTv Therapeutics and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and VTv Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on vTv Therapeutics are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of VTv Therapeutics i.e., VTv Therapeutics and Nabriva Therapeutics go up and down completely randomly.
Pair Corralation between VTv Therapeutics and Nabriva Therapeutics
Given the investment horizon of 90 days VTv Therapeutics is expected to generate 1.06 times less return on investment than Nabriva Therapeutics. In addition to that, VTv Therapeutics is 1.22 times more volatile than Nabriva Therapeutics AG. It trades about 0.01 of its total potential returns per unit of risk. Nabriva Therapeutics AG is currently generating about 0.01 per unit of volatility. If you would invest 194.00 in Nabriva Therapeutics AG on September 2, 2024 and sell it today you would lose (32.00) from holding Nabriva Therapeutics AG or give up 16.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 30.85% |
| Values | Daily Returns |
vTv Therapeutics vs. Nabriva Therapeutics AG
Performance |
| Timeline |
| vTv Therapeutics |
| Nabriva Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
VTv Therapeutics and Nabriva Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VTv Therapeutics and Nabriva Therapeutics
The main advantage of trading using opposite VTv Therapeutics and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VTv Therapeutics position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.| VTv Therapeutics vs. Tff Pharmaceuticals | VTv Therapeutics vs. Eliem Therapeutics | VTv Therapeutics vs. Inhibrx | VTv Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |